Human Photoallergy Test (824/2016)
Not Applicable
Completed
- Conditions
- Sunscreening Agents
- Interventions
- Drug: BAY987517Other: Untreated skin
- Registration Number
- NCT02962869
- Lead Sponsor
- Bayer
- Brief Summary
To evaluate the potential of a test material to produce a photoallergic response
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 53
Inclusion Criteria
- be male or female between the ages of 18 and 60 inclusive
- be lightly pigmented (Fitzpatrick Skin Type I, II, III)
- have read and signed the written Informed Consent Form and have completed a HIPAA Authorization Form (Health Insurance Portability and Accountability Act) in conformance with 45CFR Parts 160 and 164
- be in general good health as determined by the subject's medical history and in the discretion of the investigator
Exclusion Criteria
- have a visible sunburn
- have a history of sun hypersensitivity/photosensitivity or photosensitive dermatoses
- have a known hypersensitivity or allergy against any of the active and non-active ingredients of the investigational products
- subjects who are employees of the CRO (Contract Research Organization) and/or Bayer or is a household member of an employee
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description BAY987517 BAY987517 All subjects are patched with the same product BAY987517 Untreated skin All subjects are patched with the same product
- Primary Outcome Measures
Name Time Method Intensity of skin reactions is evaluated by 5 point scale Up to 72 hours
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie photoallergic reactions to BAY987517 sunscreening agents?
How does BAY987517 compare to other sunscreening agents in terms of photoallergic potential and photostability?
Are there specific biomarkers that correlate with photoallergic response risk in sunscreen clinical trials?
What are the most common adverse events associated with BAY987517 and how are they managed?
What is the current status of photoallergy testing for sunscreening agents in regulatory guidelines and Bayer's development pipeline?